Aurinia Pharmaceuticals (AUPH) PT Raised to $35 as H.C. Wainwright Sees LUPKYNIS Approval As a Watershed Event
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $35.00 (from $30.00) on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
